Oral Bisoprolol for the treatment of non-resolving central serous chorioretinopathy: A case report
<p>Purpose: To evaluate the effect of the beta blocker Bisoprolol in the treatment of chronic central serous chorioretinopathy (CSC).</p><br><p>Methods: Five patients with non-resolving CSC were treated with oral Bisoprolol 2,5 mg once a day for three months. The best-correct...
Saved in:
Main Authors: | Vingolo EM (Author), Napolitano G (Author), Rigoni E (Author), De Rosa V (Author) |
---|---|
Format: | Book |
Published: |
Journal of Clinical Research and Ophthalmology - Peertechz Publications,
2020-06-12.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Central Serous Chorioretinopathy: Treatment with Laser
by: Maurizio Battaglia Parodi, et al.
Published: (2020) -
Central Serous Chorioretinopathy Classification
by: Manuel Vilela, et al.
Published: (2020) -
Bullous Central Serous Chorioretinopathy: A Rare and Atypical Form of Central Serous Chorioretinopathy. A Systematic Review
by: Francesco Sartini, et al.
Published: (2020) -
Oral Treatment of Central Serous Chorioretinopathy Patients Using Propranolol Tablets
by: Li-Chai Chen, et al.
Published: (2020) -
The Role of Imaging in Planning Treatment for Central Serous Chorioretinopathy
by: Stefano Da Pozzo, et al.
Published: (2021)